Nanosphere Quote Page (NSPH)

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Nanosphere to Present at Jefferies 2012 Global Healthcare Conference

5/21/2012 by GlobeNewswire

Nanosphere to Host Investor Day on June 13, 2012

5/8/2012 by NASDAQ

Nanosphere management to meet with Jefferies

5/2/2012 by Theflyonthewall.com

Nanosphere Announces First Quarter 2012 Results

5/1/2012 by NASDAQ

Nanosphere reports Q1 EPS (18c), consensus (20c)

5/1/2012 by Theflyonthewall.com

Nanosphere, Inc. (NSPH) Posts Better than Expected Q1 Results

5/1/2012 by StreetInsider.com

Nanosphere Announces First Quarter 2012 Results

5/1/2012 by GlobeNewswire

Nanosphere, Thermo Fisher enter marketing/distribution agreement in Europe

4/30/2012 by Theflyonthewall.com

Nanosphere Enters Into Marketing and Distribution Agreement in Europe With Thermo Fisher Scientific

4/30/2012 by GlobeNewswire

Nanosphere to Release Q1 2012 Results and Hold Investor Call on Tuesday, May 1

4/18/2012 by GlobeNewswire

Nanosphere to Present at the 24th Annual Roth Conference

3/9/2012 by GlobeNewswire

Nanosphere reports FY11 EPS (94c) vs. consensus (21c)

2/16/2012 by Theflyonthewall.com

Nanosphere Announces Fourth Quarter and Full Year 2011 Results

2/16/2012 by GlobeNewswire

Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16

2/6/2012 by NASDAQ

Nanosphere to Release Q4 and Full Year 2011 Results and Hold Investor Call on Thursday, February 16

2/6/2012 by GlobeNewswire

Piper Jaffray's medtech research team holds a conference call

1/17/2012 by Theflyonthewall.com

Nanosphere Shares Up As FDA Approves Bacteria Diagnostic Test

12/27/2011 by RTTNews

Nanosphere (NSPH) Gets FDA 501(k) Clearance for Verigene Staphylococcus BC-S

12/27/2011 by StreetInsider.com

Nanosphere receives FDA clearance of gram-positive blood culture test

12/27/2011 by Theflyonthewall.com

Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus

12/27/2011 by GlobeNewswire

Roth Capital Starts Nanosphere (NSPH) at Neutral, $2 Price Target

12/23/2011 by StreetInsider.com

Nanosphere initiated with a Neutral at Roth Capital

12/23/2011 by Theflyonthewall.com

Morning Movers 12/21: (DFG) (NSPH) (SHAW) (FSII) Higher; (AMPE) (CVLT) (ORCL) (TIBX) Lower

12/21/2011 by StreetInsider.com

Nanosphere (NSPH) Gets CE IVD Mark for Gram-Positive BC-GP on Verigene

12/20/2011 by StreetInsider.com

Nanosphere Obtains CE Mark for Gram-Positive Blood Culture Test

12/20/2011 by GlobeNewswire

Nanosphere to Present at Piper Jaffray 23rd Annual Healthcare Conference

11/29/2011 by StockWatch

Nanosphere to Present at Piper Jaffray 23rd Annual Healthcare Conference

11/29/2011 by GlobeNewswire

Nanosphere to Present at Stephens Inc. Fall Investment Conference

11/9/2011 by GlobeNewswire

NANOSPHERE, INC. Reports Operating Results (10-Q)

11/2/2011 by GuruFocus

Nanosphere reports Q3 EPS (22c) vs. consensus (21c)

11/2/2011 by Theflyonthewall.com

Nanosphere Announces Third Quarter 2011 Results

11/2/2011 by GlobeNewswire

Healthcare Sector's Insider Buy And Sell SEC Filings From Last Week

10/25/2011 by Seeking Alpha

Nanosphere to Release Q3 2011 Results and Hold Investor Call on Wednesday, November 2

10/18/2011 by StockWatch

Nanosphere Verigene test shows high sensitivity for a broad panel of targets

9/19/2011 by Theflyonthewall.com

Nanosphere's Verigene Gram-Positive Blood Culture Test Demonstrates High Sensitivity and Specificity for a Broad Panel of Bacterial Targets

9/19/2011 by GlobeNewswire

New Emerging Medical Opportunities reports 5.2% passive stake in Nanosphere

8/16/2011 by Theflyonthewall.com

FMR LLC Lowers Stake in Nanosphere, Inc. (NSPH) to 9.33%

8/10/2011 by StreetInsider.com

UPDATE: Piper Jaffray Lowers PT on Nanosphere to $2.60

8/10/2011 by Benzinga

NANOSPHERE, INC. Reports Operating Results (10-Q)

8/9/2011 by GuruFocus

Nanosphere reports Q2 EPS (23c) vs. consensus (26c)

8/9/2011 by Theflyonthewall.com

Ticker

Nanosphere